Unlisted holdings

Data as at : 29/02/2024

% of total assets
8.0

Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.

Top holdings

Data as at : 29/02/2024

Investment % of total assets
Cytokinetics Inc 5.2
Sv Fund Vi Investment 4.8
Supernus Pharmaceuticals Inc 4.6
Gilead Sciences Inc 4.3
Biomarin Pharmaceutical Inc 4.2
Vera Therapeutics Inc Class A 4.2
United Therapeutics Corp 3.9
Incyte Corp 3.7
Amgen Inc 3.5
Scb Sholo211123b 20-Feb-2024 6.4600% 20-Mar-2024 -10.0

Geographic breakdown

Data as at : 29/02/2024

Country % of total assets
USA 75.2
Cayman Islands 5.5
Netherlands 4.5
UK 2.9
Ireland 2.9
Canada 2.6
Denmark 1.7
Germany 1.2
Sweden 0.4

Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.

Industry breakdown

Data as at : 29/02/2024

Industry % of total assets
Healthcare 101.2
Preferred 0.3
Scroll

Asset breakdown

Data as at : 29/02/2024

Asset % of total assets
Stock 103.1
Other 6.8
Bond -10.0

Detailed asset breakdown

Data as at : 29/02/2024

Asset % of total assets
North America - stock 86.3
Other 6.8
Asia (excl Japan) - stock 4.5
Europe - Small-cap stock 3.9
Other - stock 3.2
UK - Large growth stock 2.4
Europe - Large-cap stock 1.9

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.